Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 15-day vs 10-day Sequential Therapy for H. pylori
NCT01887249Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- May 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esomeprazole, amoxicillin, clarithromycin and metronidazole in Helicobacter pylori infection (3 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Helicobacter pylori eradication rate at 4 weeks. Started May 2010; status: completed.
02
Drugs
esomeprazoleamoxicillinclarithromycinmetronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT01887249.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01887249.